Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABUS

Arbutus Biopharma Corp

May 14 • 01:14PM ET

4.27

-0.04 -0.98 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARWR VIR ALNY NTLA ENTA

| Held by: VTI IWM XBI VXF IWO IBB VTWO SCHA KOMP VHT

Scroll to Statements

Index	RUT	P/E	5.19	EPS (ttm)	0.82	Insider Own	20.68%	Shs Outstand	196.95M	Perf Week	-1.89%
Market Cap	840.52M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	156.22M	Perf Month	-4.73%
Enterprise Value	749.20M	PEG	-	EPS next Q	-0.03	Inst Own	65.80%	Short Float	11.36%	Perf Quarter	6.43%
Income	160.72M	P/S	4.39	EPS this Y	32.35%	Inst Trans	1.90%	Short Ratio	8.02	Perf Half Y	-9.39%
Sales	191.44M	P/B	3.23	EPS next Y	-	ROA	81.55%	Short Interest	17.74M	Perf YTD	-11.27%
Book/sh	1.32	P/C	8.83	EPS next 5Y	-	ROE	94.73%	52W High	5.10 -16.32%	Perf Year	35.06%
Cash/sh	0.48	P/FCF	-	EPS past 3/5Y	27.57% 29.45%	ROIC	61.00%	52W Low	2.94 45.17%	Perf 3Y	68.03%
Dividend Est.	-	EV/EBITDA	4.83	Sales past 3/5Y	-28.80% 15.29%	Gross Margin	99.98%	Volatility	3.70% 4.26%	Perf 5Y	62.90%
Dividend TTM	-	EV/Sales	3.91	EPS Y/Y TTM	53.54%	Oper. Margin	81.01%	ATR (14)	0.18	Perf 10Y	-1.89%
Dividend Ex-Date	-	Quick Ratio	54.26	Sales Y/Y TTM	2889.93%	Profit Margin	83.95%	RSI (14)	45.38	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	54.26	EPS Q/Q	775.97%	SMA20	-1.76%	Beta	0.62	Target Price	5.25
Payout	-	Debt/Eq	0.02	Sales Q/Q	10054.54%	SMA50	-2.94%	Rel Volume	0.20	Prev Close	4.31
Employees	19	LT Debt/Eq	0.01	Earnings	May 13 BMO	SMA200	-0.86%	Avg Volume	2.21M	Price	4.27
IPO	Jul 23, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	3000.00% 23783.47%	Trades		Volume	266,593	Change	-0.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)